Pharma

Feb 15 2019

Zetta, Enterprise Cloud Backup – Recovery Solutions, enterprise recovery systems inc.

#Enterprise #recovery #systems #inc # Enterprise Backup Disaster Recovery Solutions Our award-winning enterprise cloud backup and restore solution is optimized for datasets up to 500 TB. Get reliable data protection for all your physical and virtual systems, so you can always recover what you need fast from and to anywhere. Push button failover protection for all of your business-critical data applications. If disaster strikes, you can have your entire IT environment operational in Zetta’s secure cloud in less than five minutes. Disaster recovery priced significantly lower than traditional providers. Enterprise-Grade Speed Reliability Performance That’s Unmatched Look around and you’ll find …

May 13 2018

Petechiae, definition of petechiae by Medical dictionary, mgi pharma inc.#Mgi #pharma #inc

petechiae pe te chi a petechiae petechiae Petechiae petechiae pe te chi ae petechiae (p t k ) , ▲ pestis fulminans pestis minor Pestivirus pestle pestology PET Pet Associated Diseases PET scan PET scanner PET scanning pet therapy peta- petal -petal petaling petalo- petaloid Petasites hybridus Petasites officinalis pet-associated disease Petaurus petazocine PETCO2 PET-CT petechia petechiae petechial petechial angiomas petechial fever petechial hemorrhage petechiasis petechiation petechiometer Peter Duesberg Peter Pan Peter Pan Wendy complex Peter Pan and Wendy Complex Peter Pan Face Peter Pan syndrome Peter/Paul Pilferage Peters Peter s anomaly Peters ovum Peters ovum Peters, Albert Peters, Hubert …

Apr 19 2018

Eagle Pharmaceuticals Receives Tentative FDA Approval for PEMFEXY (Pemetrexed Injection) Ready-to-Dilute, Eagle Pharmaceuticals Investor Center, eagle pharmaceuticals inc.#Eagle #pharmaceuticals #inc

Investors Dateline: WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) today announced that the United States Food and Drug Administration (“FDA”) has granted tentative approval for the Company’s PEMFEXY™, a pemetrexed injection ready-to-dilute formulation for locally advanced or metastatic nonsquamous non-small cell lung cancer in combination with cisplatin; locally advanced or metastatic nonsquamous non-small cell lung cancer whose disease has not progressed after four cycles of platinum-based first-line chemotherapy, as maintenance treatment; locally advanced or metastatic nonsquamous non-small cell lung cancer after prior chemotherapy as a single agent; and malignant pleural mesothelioma whose disease is unresectable or …

Apr 19 2018

Pipe Supports Systems-AAA Technology – Specialties Co, Inc, pharmaceutical specialties inc.#Pharmaceutical #specialties #inc

Pipe Supports Systems AAA Technology Specialties Co., Inc. was founded in 1971 to provide “Total Solutions Service” to the industrial piping market. We analyze, design, manufacture and supply pipe support systems for the following industries: In addition to an in-depth knowledge of pipe supports, AAA Technology also has experience with piping stress analysis. Therefore, our staff understands why a piping stress analyst selects specific pipe supports. With our broad background and extensive experience in designing, specifying, manufacturing and supplying industrial pipe support systems, AAA Technology is uniquely qualified to offer our line of engineered pipe hangers and pipe supports to …

Apr 19 2018

Alnylam, Home, alnylam pharmaceuticals inc.#Alnylam #pharmaceuticals #inc

alnylam pharmaceuticals inc To those who say “impossible, impractical, unrealistic,” we say: CHALLENGE ACCEPTED We’re relentless in our pursuit of new treatments because patients shouldn’t have to wait for hope. We are developing a new class of innovative medicines called RNAi THERAPEUTICS that we believe have the potential to transform the lives of people living with rare diseases. We are focused on diseases for which treatment options are limited or simply don’t exist. OUR ROBUST PIPELINE includes investigational RNAi therapeutics for rare genetic, cardio-metabolic, and hepatic infectious diseases. To those who say “impossible, impractical, unrealistic,” we say: CHALLENGE ACCEPTED We’re …

Apr 14 2018

Vertex Receives EU Approval for ORKAMBI – (lumacaftor, vertex pharmaceuticals inc.#Vertex #pharmaceuticals #inc

Vertex Receives EU Approval for ORKAMBI (lumacaftor/ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older with Two Copies of the F508del Mutation -In Europe, approximately 12,000 people with CF ages 12 and older have two copies of the F508del mutation- -Positive CHMP Opinion was received in September 2015 – -Country-by-country reimbursement process will now begin- LONDON –(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the European Commission has granted Marketing Authorization for ORKAMBI (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis (CF) in people ages …

Apr 12 2018

Amring Pharmaceuticals, Home, ferring pharmaceuticals inc.#Ferring #pharmaceuticals #inc

ferring pharmaceuticals inc Reliable Generics” data-link=”/management-team”> Reliable Generics” data-link=”/products”> and Reliable Generics” data-link=”/global-amring”> Amring Pharmaceuticals is a privately-held generic pharmaceutical company active in global markets geared to supplying unique and specialized products. The company is part of the global Amring Pharmaceuticals business and is partnered with well-established global biopharmaceutical companies. Amring is uniquely positioned to leverage its partners’ expertise in peptide-based drugs and biotechnology derived medicines, as well as patient-friendly drug delivery systems, sterile manufacturing and other state-of-the-art technologies. Amring is committed to putting people first in all it does, providing customers with high quality products at a reasonable cost …

Apr 12 2018

Ferring pharmaceuticals inc, ferring pharmaceuticals inc.#Ferring #pharmaceuticals #inc

ferring pharmaceuticals inc about EUFLEXXA Learn More doctor’s appointment Learn How EUFLEXXA about OA knee pain sign up This site is intended for US residents. The content on this website is for informational purposes only and is not intended to replace a discussion with a healthcare professional. EUFLEXXA® is a registered trademark of Ferring B.V. All other trademarks are property of their respective owners. ©2017 Ferring B.V. All rights reserved. 07/17 EU/1208/2015/US(1)c(1) This site is intended for US residents. The content on this website is for informational purposes only and is not intended to replace a discussion with a healthcare …

Apr 8 2018

AMYLIN AGONISTS – Anti-hyperglycemic Synthetic Analogs, pramlintide – (Symlin ® ), amylin pharmaceuticals inc.#Amylin #pharmaceuticals #inc

amylin pharmaceuticals inc SYMLIN is used with insulin and has been associated with an increased risk of insulin-induced severe hypoglycemia, particularly in patients with type 1 diabetes. When severe hypoglycemia associated with SYMLIN use occurs, it is seen within 3 hours following a SYMLIN injection. If severe hypoglycemia occurs while operating a motor vehicle, heavy machinery, or while engaging in other high-risk activities, serious injuries may occur. Appropriate patient selection, careful patient instruction, and insulin dose adjustments are critical elements for reducing this risk. Mechanism of Action SYMLIN, by acting as an amylinomimetic agent, has the following effects: 1) modulation …

Apr 8 2018

Watson pharmaceuticals inc, watson pharmaceuticals inc.#Watson #pharmaceuticals #inc

Dr. Andrew Norden, Former IBM Watson Health Deputy Chief Health Officer, Joins Cota as Chief Medical Officer Cota Expands Executive and Senior Leadership Team with Several Healthcare and Information Technology Veterans News provided by Sep 13, 2017, 06:00 ET Share this article NEW YORK , Sept. 13, 2017 /PRNewswire/ — Cota, a healthcare data and analytics company that bridges precision medicine to population health, today announced that Andrew Norden , MD, MPH, MBA, has joined Cota as Chief Medical Officer (CMO). With his extensive clinical expertise and background in healthcare data analytics, the board-certified neurologist and neuro-oncologist will oversee the …

Mar 4 2018

Extracellular fluid, definition of extracellular fluid by Medical dictionary, akela pharma inc.#Akela #pharma #inc

extracellular fluid Related to extracellular fluid: intracellular fluid ex tra cel lu lar flu id (ECF), extracellular fluid (ECF) extracellular fluid ex tra cel lu lar flu id extracellular fluid extracellular ▲ extraanatomic bypass extra-anatomic vascular bypass extraarticular extra-articular extraaxial extrabuccal extrabulbar extracaliceal extracampic hallucination extracampine hallucination extracapsular extracapsular ankylosis extracapsular dendrite extracapsular extension extracapsular extraction extracapsular fracture extracapsular ligament extracapsular ligaments extracapsular rupture extracardiac extracardiac murmur extracarpal extracellular extracellular digestion extracellular enzyme extracellular fluid extracellular fluid volume extracellular iodophilia extracellular matrix extracellular space extrachorial placentation extrachorial pregnancy extrachromosomal extrachromosomal DNA extrachromosomal element extrachromosomal gene extrachromosomal inheritance extracoronal extracoronal retainer …

Mar 1 2018

Farmacie Online Chisinau, ucb pharma inc.#Ucb #pharma #inc

ucb pharma inc Pe categorii Cauta medicament Farmacie Online Chişinău Farmacia online vă prezintă primul site farmaceutic profesionist din Republica Moldova. n farmacie şi pe site-ul nostru puteţi găsi peste 5.000 de medicamente omologate n Republica Moldova şi toate produsele parafarmaceutice necesare zi de zi. Astfel, acces nd site-ul nostru, găsiţi toate produsele de care aveţi nevoie fără a mai alerga de la o farmacie la alta şi fără a sta la coadă. Citiţi on line informaţia despre produsele care vă interesează şi comandaţi-le on line cu livrare la domiciliu sau la altă adresa. Momentan farmacia nu functioneaza. Noutati Helmizol …

Feb 15 2018

Eagle pharmaceuticals inc, eagle pharmaceuticals inc.#Eagle #pharmaceuticals #inc

eagle pharmaceuticals inc Active Cases KCC Precedent Client Login Active Cases KCC Precedent Client Login Search All KCC Documents KCC Precedent Search Options KCC’s Corporate Restructuring Court Documents Search provides access to thousands of historical court documents located on KCC public access websites. Please use the form below to refine and maximize search results. For information about the data provided, please review the Disclaimer statement. Disclaimer + – Kurtzman Carson Consultants LLC (“KCC”) does not guarantee or warrant that the data provided herein is accurate, complete, or current and shall not be liable to you for any loss or injury …

Feb 15 2018

Bakken Resources, Inc, eagle pharmaceuticals inc.#Eagle #pharmaceuticals #inc

Bakken Resources, Inc. Announces Entry Into Term Sheet Financing News provided by May 09, 2016, 17:02 ET Share this article HELENA, Mont. , May 9, 2016 /PRNewswire/ — Bakken Resources, Inc. (OTCQX: BKKN) (“Bakken,” “BRI,” “us,” “we,” or the “Company”) announces its entry into a term sheet on May 3 , 2016 with Eagle Private Equity (“Eagle”), a New York -based private equity firm, for debt and equity financing (the “Term Sheet”). The Term Sheet provides for an immediate $1 million credit line to be provided by Eagle, along with a subsequent debt or equity financing of up to $10 …

Feb 15 2018

EGRX stock quote – Eagle Pharmaceuticals, Inc, eagle pharmaceuticals inc.#Eagle #pharmaceuticals #inc

Eagle Pharmaceuticals, Inc. Common Stock Quote & Summary Data Stock Details COMPANY NEWS FUNDAMENTALS Edit Symbol List Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages. Don’t know the stock symbol? Use the Symbol Lookup tool. Alphabetize the sort order of my symbols Symbol Lookup Investing just got easier Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow. “Best Ask” is the lowest price currently being asked …

Feb 15 2018

Eagle Pharmaceuticals Receives Tentative FDA Approval for PEMFEXY (Pemetrexed Injection) Ready-to-Dilute, Eagle Pharmaceuticals Investor Center, eagle pharmaceuticals inc.#Eagle #pharmaceuticals #inc

Investors Dateline: WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) today announced that the United States Food and Drug Administration (“FDA”) has granted tentative approval for the Company’s PEMFEXY™, a pemetrexed injection ready-to-dilute formulation for locally advanced or metastatic nonsquamous non-small cell lung cancer in combination with cisplatin; locally advanced or metastatic nonsquamous non-small cell lung cancer whose disease has not progressed after four cycles of platinum-based first-line chemotherapy, as maintenance treatment; locally advanced or metastatic nonsquamous non-small cell lung cancer after prior chemotherapy as a single agent; and malignant pleural mesothelioma whose disease is unresectable or …

Feb 14 2018

Pipe Supports Systems-AAA Technology – Specialties Co, Inc, pharmaceutical specialties inc.#Pharmaceutical #specialties #inc

Pipe Supports Systems AAA Technology Specialties Co., Inc. was founded in 1971 to provide “Total Solutions Service” to the industrial piping market. We analyze, design, manufacture and supply pipe support systems for the following industries: In addition to an in-depth knowledge of pipe supports, AAA Technology also has experience with piping stress analysis. Therefore, our staff understands why a piping stress analyst selects specific pipe supports. With our broad background and extensive experience in designing, specifying, manufacturing and supplying industrial pipe support systems, AAA Technology is uniquely qualified to offer our line of engineered pipe hangers and pipe supports to …

Feb 14 2018

Pharmaceutical specialties inc, pharmaceutical specialties inc.#Pharmaceutical #specialties #inc

pharmaceutical specialties inc See More Solutions A.D.A.M. Consumer Health, the most credible source of health care information and interactive tools for hospitals and health care organizations, has the solutions you need to succeed in today’s competitive environment. With decades of experience, A.D.A.M. provides world-class client service, strategic consultation, and flexible implementation—options to help you maximize the benefits of its expanding suite of products. A.D.A.M. Education is the leader in innovative content and curriculum resources for teaching and learning about the human body and improving health literacy. A.D.A.M. Education resources bring anatomy to life by providing a unique interactive learning experience …

Feb 11 2018

Ferring pharmaceuticals inc#Ferring #pharmaceuticals #inc

ferring pharmaceuticals inc PREPOPIK ® How to Take About PREPOPIK ® How to Take Pay No More The efficacy doctors need. In a clinical trial, 96% of patients said they would take Split Dose PREPOPIK ® again and 89% found it very easy or easy to take vs 55% and 29%, respectively, for a Day-Before comparator (2L PEG+E plus 2 x 5 mg bisacodyl tablets) PREPOPIK ® has been found effective as a bowel prep in both Split-Dose and Day-Before dosing regimens. Learn more Indication and Important Safety Information PREPOPIK ® is a prescription medicine used by adults to clean …

Feb 11 2018

Information Hospitali – re – L actualit – m – dicale et hospitali – re en ligne, ferring pharmaceuticals inc.#Ferring #pharmaceuticals #inc

ferring pharmaceuticals inc Sous l’autoritй du Directeur, le Responsable des R . L’Hфpital Gйrontologique de Chevreuse, йtablisseme . Afin de complйter son йquipe d’animation, l’hфpita . 3 secteurs d?activitйs : Actus santй Dйmographie : mйdecin traitant, un mйtier en perdition ? Les gйnйralistes seraient ils en voie de disparition ? C’est ce que pourrait suggйrer l’atlas 2015 de la dйmographie mйdicale prйsentй, mardi 16 juin 2015 par le Conseil national de l’ordre des mйdecins (CNOM). Tour d’horizon d’une profession vieillissante… Zona : un vaccin enfin disponible. Depuis lundi 15 juin 2015, un nouveau vaccin a fait son apparition sur le …

Feb 10 2018

Teva Pharmaceuticals USA, Inc, king pharmaceuticals inc.#King #pharmaceuticals #inc

Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. Holding: When reviewing a district court’s resolution of subsidiary factual matters made in the course of its construction of a patent claim, the Federal Circuit must apply a “clear error,” not a de novo, standard of review. Judgment: Reversed and remanded, 7-2, in an opinion by Justice Breyer on January 20, 2015. Justice Thomas filed a dissenting opinion, in which Justice Alito joined. SCOTUSblog Coverage Breyer turns down generic firms’ plea (Lyle Denniston) New dispute over Copaxone patent (FURTHER UPDATED) (Lyle Denniston) Opinion analysis: Court moves to rein in Federal Circuit control over …

Feb 9 2018

Federal Trade Commission v, solvay pharmaceuticals inc.#Solvay #pharmaceuticals #inc

Federal Trade Commission v. Actavis Disclosure: Goldstein & Russell, P.C., whose attorneys work for or contribute to this blog in various capacities, also represented Louisiana Wholesale Drug Company et al. as an amicus in support of the petitioner in this case. Holding: Governments and private parties may bring lawsuits against brand-name drug manufacturers to challenge the drug companies’ payments to would-be competitors who make generic substitutes to keep the generic substitutes out of the market, but those payments are not presumptively illegal. Judgment: Reversed, 5-3, in an opinion by Justice Breyer on June 17, 2013. Chief Justice Roberts filed a …

Feb 8 2018

Enanta Pharmaceuticals to Present New Preclinical Data on EDP-305, an FXR Agonist for NASH and PBC, at The Liver Meeting – 2017, Business Wire, watson pharmaceuticals inc.#Watson #pharmaceuticals #inc

Enanta Pharmaceuticals to Present New Preclinical Data on EDP-305, an FXR Agonist for NASH and PBC, at The Liver Meeting® 2017 WATERTOWN, Mass.–( BUSINESS WIRE )–Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a chemistry-driven biotechnology company dedicated to creating and developing small molecule drugs for viral infections and liver diseases, today announced new data presentations on EDP-305, Enanta’s lead Farnesoid X receptor (FXR) agonist being developed for non-alcoholic steatohepatitis (NASH) and primary biliary cholangitis (PBC), will be presented at The Liver Meeting® 2017, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place October 20-24, 2017 in …

Jan 16 2018

Campaign Middle East, The latest news for the advertising and media industry, Visit Campaign – s website for brands, ad agencies – to watch ads, akela pharma inc.#Akela #pharma #inc

Campaign Middle East The industry is going through an intense period of change. Clients’ business models are threatened by a bevy of new and unexpected competitors, advertising agencies are being challenged by consultancies and media owners are confronted by the dominance of Facebook and Google. What’s at the heart of all of this? Digital technology. Why? Because it’s [ ] We’re experiencing a period of rapid transformation right now, with technology becoming increasingly (and almost invisibly) a part of us. This merge not only closes the gap between humans and machines, but it also generates vast amounts of data with …

Jan 16 2018

Extracellular fluid, definition of extracellular fluid by Medical dictionary, akela pharma inc.#Akela #pharma #inc

extracellular fluid Related to extracellular fluid: intracellular fluid ex tra cel lu lar flu id (ECF), extracellular fluid (ECF) extracellular fluid ex tra cel lu lar flu id extracellular fluid extracellular ▲ extraanatomic bypass extra-anatomic vascular bypass extraarticular extra-articular extraaxial extrabuccal extrabulbar extracaliceal extracampic hallucination extracampine hallucination extracapsular extracapsular ankylosis extracapsular dendrite extracapsular extension extracapsular extraction extracapsular fracture extracapsular ligament extracapsular ligaments extracapsular rupture extracardiac extracardiac murmur extracarpal extracellular extracellular digestion extracellular enzyme extracellular fluid extracellular fluid volume extracellular iodophilia extracellular matrix extracellular space extrachorial placentation extrachorial pregnancy extrachromosomal extrachromosomal DNA extrachromosomal element extrachromosomal gene extrachromosomal inheritance extracoronal extracoronal retainer …

Jan 15 2018

Dry Mouth * ENT Surgical Consultants * Ear Nose Throat * Chicagoland ENT Doctors * Joliet * Morris IL, mgi pharma inc.#Mgi #pharma #inc

Dry Mouth A healthy mouth contains three pairs of major salivary glands, as well as minor saliva glands. These glands produce saliva, which flow into your mouth as needed. You need more saliva when you are eating, for instance, than when you are sleeping. Saliva is one of those things you do not appreciate until it is gone. Saliva moistens the mouth, and that moisture helps you talk, eat, swallow, and keep your teeth and gums healthy. When your body fails to produce enough saliva or changes the saliva composition, the condition is called xerostomia, or more commonly, dry mouth. …

Jan 15 2018

Petechiae, definition of petechiae by Medical dictionary, mgi pharma inc.#Mgi #pharma #inc

petechiae pe te chi a petechiae petechiae Petechiae petechiae pe te chi ae petechiae (p t k ) , ▲ pestis fulminans pestis minor Pestivirus pestle pestology PET Pet Associated Diseases PET scan PET scanner PET scanning pet therapy peta- petal -petal petaling petalo- petaloid Petasites hybridus Petasites officinalis pet-associated disease Petaurus petazocine PETCO2 PET-CT petechia petechiae petechial petechial angiomas petechial fever petechial hemorrhage petechiasis petechiation petechiometer Peter Duesberg Peter Pan Peter Pan Wendy complex Peter Pan and Wendy Complex Peter Pan Face Peter Pan syndrome Peter/Paul Pilferage Peters Peter s anomaly Peters ovum Peters ovum Peters, Albert Peters, Hubert …

Jan 12 2018

Profiles of Major Products under Development, Clinical Development, Research and Development, Sumitomo Dainippon Pharma, sankyo pharma inc.#Sankyo #pharma #inc

Profiles of Major Products *as of October 30, 2017 LATUDA В® (lurasidone hydrochloride)гЂЂAtypical antipsychotic Developed in-house LATUDA В® (lurasidone hydrochloride) is an atypical antipsychotic agent that is believed to have an affinity for dopamine D2, serotonin 5-HT2A and serotonin 5-HT7 receptors where it has antagonist effects. In addition, LATUDA is a partial agonist at the serotonin 5-HT1A receptor and has no appreciable affinity for histamine H1 or muscarinic M1 receptors. Approved country and area: Schizophrenia 2010: U.S., 2012: Canada, 2013: Switzerland, 2014: Europe and Australia, 2016: Taiwan, Russia, Singapore, Thailand and Hong Kong, 2017: Brazil Bipolar I depressionгЂЂ 2013: U.S., …

Jan 12 2018

Strategy, advocacy and partnering for the orphan drug industry, Orphan, sankyo pharma inc.#Sankyo #pharma #inc

2017В BROCHURE Download the brochure to find out exactly what’s in store for this year’s event. OUR HISTORY The 8th annual World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug development, from clinical development and R width: 250px; margin: 0 10px 5px 0;” src=”https://www.terrapinn-cdn.com/conference/world-orphan-drug-congress/Img/sven-kili-150.jpg” />Sven Kili Vice President and Head of Gene Therapy Development Dr Carlo IncertiВ SVP, Head of Global Medical Affairs, CMO Genzyme, A Sanofi Company Chief Executive Officer Dr Bruno Sepodes Genetic Alliance UK EUROPE’S MEETING PLACE FOR THE RARE DISEASE COMMUNITY The Conference offers strategic …

Jan 10 2018

Eagle pharmaceuticals inc, eagle pharmaceuticals inc.#Eagle #pharmaceuticals #inc

eagle pharmaceuticals inc Active Cases KCC Precedent Client Login Active Cases KCC Precedent Client Login Search All KCC Documents KCC Precedent Search Options KCC’s Corporate Restructuring Court Documents Search provides access to thousands of historical court documents located on KCC public access websites. Please use the form below to refine and maximize search results. For information about the data provided, please review the Disclaimer statement. Disclaimer + – Kurtzman Carson Consultants LLC (“KCC”) does not guarantee or warrant that the data provided herein is accurate, complete, or current and shall not be liable to you for any loss or injury …

Jan 10 2018

Eagle Pharmaceuticals Receives Tentative FDA Approval for PEMFEXY (Pemetrexed Injection) Ready-to-Dilute, Eagle Pharmaceuticals Investor Center, eagle pharmaceuticals inc.#Eagle #pharmaceuticals #inc

Investors Dateline: WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) today announced that the United States Food and Drug Administration (“FDA”) has granted tentative approval for the Company’s PEMFEXY™, a pemetrexed injection ready-to-dilute formulation for locally advanced or metastatic nonsquamous non-small cell lung cancer in combination with cisplatin; locally advanced or metastatic nonsquamous non-small cell lung cancer whose disease has not progressed after four cycles of platinum-based first-line chemotherapy, as maintenance treatment; locally advanced or metastatic nonsquamous non-small cell lung cancer after prior chemotherapy as a single agent; and malignant pleural mesothelioma whose disease is unresectable or …

Jan 10 2018

Eagle Pharmaceuticals Receives Tentative FDA Approval for PEMFEXY (Pemetrexed Injection) Ready-to-Dilute, Eagle Pharmaceuticals Investor Center, eagle pharmaceuticals inc.#Eagle #pharmaceuticals #inc

Investors Dateline: WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) today announced that the United States Food and Drug Administration (“FDA”) has granted tentative approval for the Company’s PEMFEXY™, a pemetrexed injection ready-to-dilute formulation for locally advanced or metastatic nonsquamous non-small cell lung cancer in combination with cisplatin; locally advanced or metastatic nonsquamous non-small cell lung cancer whose disease has not progressed after four cycles of platinum-based first-line chemotherapy, as maintenance treatment; locally advanced or metastatic nonsquamous non-small cell lung cancer after prior chemotherapy as a single agent; and malignant pleural mesothelioma whose disease is unresectable or …

Jan 10 2018

2018 BIO International Convention, alnylam pharmaceuticals inc.#Alnylam #pharmaceuticals #inc

BIO 2018 Housing Choose from 29 hotels near the Boston Convention Exhibition Center. Meet the BIO 2018 These impressive Massachusetts-based leaders are already hard at work for #BIO2018! BIO Buzz Center Interview with Jim Greenwood The state of the biotechnology industry and what it means for innovation in 2018. BIO Buzz Center Interview with Kate Rubins, NASA Learn about her first spaceflight on Expedition 48/49, where she became the first person to sequence DNA in space. BIO 2017 BIO 2017 in San Diego broke all the records. Check out all of the impressive stats: Experience BIO 2017 Online Watch the …

Jan 10 2018

Hold On To Alnylam Pharmaceuticals In 2017 – alny, Seeking Alpha, alnylam pharmaceuticals inc.#Alnylam #pharmaceuticals #inc

alnylam pharmaceuticals inc Hold On To Alnylam Pharmaceuticals In 2017 Patisiran is inching closer to securing regulatory approvals across the world. Fitusiran may also become a major contributor to Alnylam Pharmaceuticals’ revenue growth in future years. Phase 3 program for investigational therapy, Givosiran, has received a go-ahead from FDA. Investors cannot ignore certaincompany specific risks. Striding incessantly towards the target of having three commercialized products in its portfolio by end of year 2020, Alnylam Pharmaceuticals (NASDAQ:ALNY) is definitely a very interesting investment opportunity in 2017. The year 2017 has proved to be pivotal for the company, with lead investigational RNAi …

Jan 7 2018

Astellas Pharma, Inc #ajanta #pharma

#astellas pharma # Astellas Pharma, Inc. Business summary Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focuses on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. Its global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan. In the news TOKYO — Interest in stocks backed by stable earnings and dividends as an alternative to low-yielding bonds is waning in Japan in favor of undervalued cyclical stocks, a …

Dec 27 2017

Contract Pharma – PROTECS Inc #pharma #advertising #agencies

#contract pharma # Project Delivery, Empowering Breakthrough You support the development of life-changing breakthroughs, and your facility is a critical driver of your ability to deliver results. Our evolved model for full service project delivery is tailor made to serve contract service organizations by creating spaces that empower them to perform efficiently and reliably for their customersat a competitive cost. The external pressures on contract service organizations to be held to highest standards of compliance buy yet design, build and validate a facility that is cost effective and competitive to their competition, is imperative for their success. PROTECS understands these …

Dec 25 2017

Helvoet Pharma, Inc #drug #research #companies

#helvoet pharma # Helvoet Rubber Plastic Technologies, established in 1939, is internationally active in custom-made development and manufacturing of rubber and plastic components and assemblies. HelvoetÕs competitive advantage lies in developing and manufacturing complete functional modules for a number of product groups in various application areas. For assembled products, the application of innovative rubber, plastic and assembly technology plays a prominent role. Due to many decades of experience, Helvoet accumulated unique expertise and knowledge of product development and various production processes for rubber and plastic products, for instance as a supplier to the automotive industry. Optimal process control is central …

Dec 23 2017

Pharma Search Partners, Inc #catalent #pharma

#pharma recruiters # Pharma Search Partners, LLC We are a pharmaceutical industry placement service specializing in the placement of highly skilled professionals in permanent or temporary positions. Pharma-Search Partners is an equal opportunity employer and maintains a strong commitment to diversity in the workplace. Our client list includes highly respected Fortune 500 pharmaceutical companies. Pharma Search Partners has established its solid reputation through a sincere commitment to personal service. Commitment to excellence and integrity in dealing with both company clients and candidates alike has helped establish us as one of the leading placement firms in the area. Our strengths over …

Dec 22 2017

MDS sells late stage trial unit to INC Research #pharmaceutical #formulations

#mds pharma services # MDS sells late stage trial unit to INC Research By Gareth Macdonald Gareth Macdonald 02-Jun-2009 2009-06-02T00:00:00Z Last updated on 02-Jun-2009 at 13:32 GMT 2009-06-02T13:32:27Z Canadian CRO MDS Pharma Services (MDS) is to sell its Phase II-IV trial business to US counterpart INC Research for $50m (€35m) and focus on providing discovery and early clinical development services. Pharma services president David Spaight told Outsourcing-pharma.com that the divestiture “was driven by the company’s desire to focus its business portfolio on areas where it believes it can expand market leadership. “The current economy continues to impact the life sciences …

Dec 8 2017

Hi-Tech Pharmaceuticals, Inc #what #is #the #pharmaceutical #industry

#hitech pharma # Hi-Tech Pharmaceuticals, Inc. 4/22/15 This letter concerns your products Fastin -XR, Fastin Rapid Release, and Lipodrene Extended Release, which are labeled and/or offered for sale as dietary supplements. Your product labeling lists the substance R-beta-methylphenethylamine as a dietary ingredient in the form of an extract of Acacia rigidula (leaves). This ingredient is also called, among other names, Beta-methylphenethylamine, MePEA, or BMPEA (hereinafter referred to as BMPEA). Under section 201(ff)(1) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. 321(ff)(1)], a dietary ingredient is a vitamin; mineral; herb or other botanical; amino acid; dietary substance …

Dec 8 2017

Sankyo pharma inc #pharmaceutical #distributors

#sankyo pharma inc # Contact Us Headquarters Daiichi Sankyo Co. Ltd 3-5-1, Nihonbashi Honcho, Chuo-ku, Tokyo 103-8426 Japan

Dec 8 2017

DUSA – News and Analysis – DUSA Pharmaceuticals, Inc #jobs #in #pharmaceutical #industry

#dusa pharma # DUSA is a vertically integrated dermatology company that is developing and marketing Levulan PDT and other products for common skin conditions. We operate in two segments, Photodynamic Therapy, or PDT, Drug and Device Products and Non-Photodynamic Therapy, or Non-PDT, Drug Products. Our Levulan® Kerastick® and BLU-U® products comprise our PDT segment, while Nicomide®, ClindaReach® and the other products acquired in the acquisition of Sirius comprise our Non-PDT segment. Our currently marketed products include among others Levulan® Kerastick® 20% Topical Solution with photodynamic therapy, the BLU-U® brand light source, and certain products acquired in the March 10, 2006 …

Dec 7 2017

Onyx Pharmaceuticals, Inc #exl #pharma

#onyx pharma # Welcome to the Onyx Pharmaceuticals, Inc. Shareholder Litigation Website This website has been established to provide general information regarding the Onyx Pharmaceuticals, Inc.(“Onyx”) Shareholder Litigation, pending in the Superior Court of California, County of San Mateo (the “Court”). The capitalized terms used on this website and not defined herein shall have the same meanings ascribed to them in the Order Granting Class Certification dated April 10, 2015. If you were a holder of Onyx common stock who received consideration for their shares in the Acquisition of Onyx by Amgen at the price of $125.00 per share who …

Dec 6 2017

LGM Pharma @, Inc #astellas #pharma #inc

#lgm pharma # LGM Pharma’s mission is to support our client�s drug development and commercialization activities by providing the highest quality and most suitable pharmaceutical ingredients (APIs) complimented with a full service essential for our clients to achieve success. As a privately owned family business, LGM Pharma has been supplying quality APIs for three generations. We have developed strong partnerships with top API producers, contract manufacturers and custom synthesis laboratories around the world. Our expertise allows us to support our clients throughout their entire critical path of drug development, from discovery to commercial production: Customer Driven: At LGM Pharma, our …

Dec 6 2017

Kyowa Kirin Pharmaceutical Research, Inc #basf #pharma

#pharmaceutical research jobs # Job Openings Current Opportunities We seek highly motivated individuals, who work well independently and with others to contribute to the success of our organization. Position: Senior Research Associate – Molecular Biology FSLA Status: Exempt Summary: Kyowa Kirin Pharmaceutical Research, Inc. a wholly owned subsidiary of Kyowa Hakko Kirin, Co. Ltd. is seeking a highly motivated Senior Research Associate with demonstrated technical and analytical competence in the area of Molecular Biology to support the discovery of novel therapeutics for autoimmune and inflammatory diseases indications. Essential Duties and Responsibilities include the following. Other duties may be assigned. Independently …

Dec 6 2017

Robinson Pharma Inc #top #20 #pharma

#robinson pharma # Robinson Pharma, Inc. Introduces the Unique and Innovative Vegan Multivitamin Softgel Robinson Pharma, Inc. is pleased to introduce the state-of-the-ar t vegan softgel multivitamin to the health marketplace. As the first of its kind, the vegan multivitamin consists of over 20 vitamins, minerals, and nutrients, encapsulated in one sleek softgel for an easy-to-swallow dosage. With a thinner and more compact design than traditional multivitamins, the multivitamin softgel delivers nutrients that are… 1 сентября в 17:57 · Доступно всем Robinson Pharma, Inc. Extends Organic Production Certification to Softgel and Liquid Manufacturing Facilities Robinson Pharma, Inc. is pleased to …

Nov 29 2017

Astellas Pharma US, Inc #real #pharma

#astellas pharma # Astellas Pharma US, Inc. Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this page …

Nov 29 2017

Sankyo pharma inc #pharmaceuticals #jobs

#sankyo pharma inc # Contact Us Headquarters Daiichi Sankyo Co. Ltd 3-5-1, Nihonbashi Honcho, Chuo-ku, Tokyo 103-8426 Japan

Nov 27 2017

MDS sells late stage trial unit to INC Research #pharma #industry #trends

#mds pharma services # MDS sells late stage trial unit to INC Research By Gareth Macdonald Gareth Macdonald 02-Jun-2009 2009-06-02T00:00:00Z Last updated on 02-Jun-2009 at 13:32 GMT 2009-06-02T13:32:27Z Canadian CRO MDS Pharma Services (MDS) is to sell its Phase II-IV trial business to US counterpart INC Research for $50m (€35m) and focus on providing discovery and early clinical development services. Pharma services president David Spaight told Outsourcing-pharma.com that the divestiture “was driven by the company’s desire to focus its business portfolio on areas where it believes it can expand market leadership. “The current economy continues to impact the life sciences …

Nov 24 2017

Moleculin Biotech – Moleculin Biotech, Inc #pharma #social #media

#pharmaceutical companies in houston tx # Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Advancing breakthrough therapeutic approaches to cancer In a Phase II clinical trial, Annamycin was given to patients who had failed an average of five previous induction therapy attempts, and 30% of those patients cleared enough of their leukemic cells to qualify for a bone marrow transplant By reducing the …